Chemical formula: C₈H₁₀N₂O₃S Molecular mass: 214.242 g/mol PubChem compound: 5320
The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D10AF06 | D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne | |
| S01AB04 | Sulfacetamide | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AB Sulfonamides |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| KLARON Lotion | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Sulfacetamide is an active ingredient of these brands:
United States (US)
Brazil (BR)
Canada (CA)
Ecuador (EC)
Israel (IL)
Mexico (MX)
South Africa (ZA)
Spain (ES)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
